What happened
HLB Genex reported consolidated results for FY2025: revenue of US$29.5M (+22.4% year on year), operating profit of US$820K (from a loss a year earlier) and net income of US$15.6M (from a loss a year earlier).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$29.5M |
|---|---|
| Revenue vs a year earlier | +22.4% |
| Operating profit | US$820K |
| Net income | US$15.6M |
| Period | FY2025 (consolidated) |
| Filed | 2026-03-13, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260313900683 → open original filing |
Source: DART. Information only, not investment advice.